We describe a simple method of tracking oxygen in real-time with injectable, tissue-integrating microsensors. The sensors are small (500 μm × 500 μm × 5 mm), soft, flexible, tissue-like, biocompatible hydrogels that have been shown to overcome the foreign body response for long-term sensing. The sensors are engineered to change luminescence in the presence of oxygen or other analytes and function for months to years in the body. A single injection followed by non-invasive monitoring with a hand-held or wearable Bluetooth optical reader enables intermittent or continuous measurements. Proof of concept for applications in high altitude, exercise physiology, vascular disease, stroke, tumors, and other disease states have been shown in mouse, rat and porcine models. Over 90 sensors have been studied to date in humans. These novel tissue-integrating sensors yield real-time insights in tissue oxygen fluctuations for research and clinical applications.
equipment, lack accuracy, and/or typically require anesthesia or restraint, thereby excluding the possibility for real-time monitoring during daily life [5] . This report summarizes ongoing NIH and DARPA funded research on the development of novel, low-cost, tissue-integrating sensors that enable real-time continuous measurement of tissue oxygen for months to years, with special focus on continuous hypoxia monitoring for localized tissue ischemia and systemic oxygenation inferred from local measurements in healthy tissue.
The foreign body response (FBR) has long been known as the major culprit in developing long-term accurate in vivo biosensors [6] [7] [8] . To overcome the FBR in designing long-term oxygen sensors, we begin with soft, tissue-like, hydrogel scaffold materials [9, 10] , originally developed for tissue engineering applications. Within this hydrogel, nano/molecular sensors are engineered to optically report oxygen levels (or other analyte levels of interest depending on the recognition element selected). Dyes are synthetically engineered to emit in the near infra-red (optical window of the skin), covalently link to the hydrogel backbone, and be stable under in vivo conditions. The specially designed micro-architecture of the hydrogel sensor contains over 60% void space and encourages tissue and capillary growth into and throughout the entire sensor ( Fig. 49.1 ). Unlike other implantable sensors, the porous hydrogel has a large surface area for analyte diffusion. In addition, the use of soft, tissue-like materials reduces the likelihood of biomechanical factors affecting the long-term sensor acceptance in tissue [11, 12] .
Methods

Tissue-Integrating Sensor
The particular injectable microsensors reported here are composed of a biocompatible hydrogel, poly (2-hydroxyethyl methacrylate) (pHEMA) and a near infrared (NIR) oxygen-sensitive palladium-benzoporphyrin molecule (Pd-MABP) [13] . The microsensor measures oxygen in the body based on the principle of phosphorescence quenching of metalloporphyrins, a well-established technique with excellent sensitivity and specificity to physiologic oxygen [14] [15] [16] [17] . The pHEMA hydrogel is biocompatible, has good oxygen permeability, excellent mechanical properties, and a long history of use in medical devices [18] . The Pd-MABP molecules are covalently attached to the pHEMA hydrogel, ensuring that the sensing chemistry is retained in the hydrogel structure. To create the tissue-integrating properties, prepolymer solution is filled into tubes of various sizes into which quality-controlled, monodisperse templating beads have been close-packed and sintered. Pre-polymer solution is crosslinked, and tubes and sintering beads are removed through solvent dissolution [9, 10] . The miniature sensors (0.5 mm × 0.5 mm × 5 mm) are designed to remain in the body permanently; they are soft and tissue-like to minimize stress at the material-tissue interface caused by motion and pressure, which can damage or stimulate adjacent immune cells and prolong the inflammatory phase [11, 19 ].
Non-invasive Optical Reader
A non-invasive optical reader for use on animals and humans was designed to read the signals from injected tissue-integrating sensors (Concept in Fig. 49 .1c and prototype shown in 49.2d). A reader is manually positioned over a sensor and taped into place. A thermometer built into the surface of the reader continuously allows for temperature correction. An LED pulses illumination light into the skin above the sensors, and a photodetector collects emission light emanating from the sensor.
The phosphorescent lifetime, a property of the oxygen sensitive dye, is measured, thereby providing a signal unaffected by optical path permutations such as blood flow fluctuations, tissue ingrowth, oxy/deoxyhemoglobin ratio, melanin content and hydration [20] .
The current oxygen sensing system can measure lifetime to within 2 μs or better, which equates to ~1 μM O 2 , allowing good resolution within the observable range to date (2-70 μM).
In Vivo Application
In the work presented here sensors are injected with a 16 or 18-gauge needle in the subcutaneous tissue or other soft tissue of interest (brain, muscle, tumor). Sensors are visualized with the Perkins Elmer IVIS Imager in small animal models. Fluorescence from serial IVIS images is plotted to show changes in relative oxygen over time in response to challenges such as cycling fraction of inspired oxygen (fiO 2 ) from 1.00 down to 0.12 in anesthetized mice, rats, and pigs. For quantitative O 2 measurements derived from phosphorescent lifetime decay, the prototype optical reader described above and pictured in Fig. 49.2d is placed over the sensors. For the purpose of this manuscript, O 2 is reported in relative units to clearly visualize fluctuation in response to oxygen challenges. Several hundred sensors have been optimized in mice, rats, and pigs. Over 90 sensors have been tested in humans including 50 in healthy volunteers and 40 in critical limb ischemia patients [21] . The benefits of such O 2 sensing technology is the ability to non-invasively monitor status of tissue in a continuous, mobile format. The cost of instrumentation is orders of magnitude cheaper than MRI or EPR, however with lower spatial resolution. Repeated insertions and perturbations of tissue that are required by percutaneous fiber optics or Clark electrodes are eliminated. Furthermore, the luminescent lifetime measurement technique is immune to errors from movement, injection depth (<1 cm), or other optical artifacts (e.g., blood flow, oxy/deoxyhemoglobin ratio) [20] .
Results
Some challenges of the luminescent tissue-integrating technology include temperature sensitivity and depth. Current surface temperature correction may be improved in the future by incorporation of temperature sensitive luminophores into the hydrogel. Current injectable sensors are limited to ~1 cm depth due to sensor brightness, which could be enhanced by creating larger sensors, though must be balanced with trade-offs (e.g., patient inconvenience). Sensors may be engineered through formulation optimization to enhance brightness for monitoring deeper tissues. Capillary blood glucose is indicated with triangles. These preliminary data demonstrate the proofof-concept application of the luminescent hydrogel sensor to extend beyond continuous measurement of oxygen
Conclusions
Tissue-integrating hydrogel microsensors enable continuous in vivo monitoring to provide powerful insights into tissue-level physiology with the potential to help make more informed therapeutic, real-time decisions about various disease states. The methods discussed present potential cost-and time-effective methods to monitor tissue oxygenation long-term in pre-clinical and clinical situations.
